Janone Inc. (NASDAQ:ALTS - Get Free Report) was the target of a significant growth in short interest in the month of February. As of February 15th, there was short interest totalling 235,000 shares, a growth of 50.4% from the January 31st total of 156,300 shares. Approximately 1.7% of the company's stock are short sold. Based on an average daily trading volume, of 238,700 shares, the short-interest ratio is presently 1.0 days.
Janone Price Performance
ALTS traded down $0.18 on Thursday, hitting $5.36. The company had a trading volume of 86,339 shares, compared to its average volume of 242,333. The company has a debt-to-equity ratio of 1.96, a quick ratio of 0.75 and a current ratio of 0.75. Janone has a 52-week low of $1.29 and a 52-week high of $7.75. The stock has a fifty day simple moving average of $5.83 and a 200-day simple moving average of $3.64.
About Janone
(
Get Free Report)
ALT5 Sigma Corp. is a clinical-stage biopharmaceutical company, which engages in identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of pain and addiction. It operates under the Biotechnology and Recycling segments.
Further Reading
Before you consider Janone, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Janone wasn't on the list.
While Janone currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for March 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
